Low molecular weight heparin and pentasaccharide (fondaparinux) approved for the treatment of pulmonary embolism
 |
|
All regimens administered subcutaneously.
IU = international units; LMWH = low molecular weight heparin.
aOnce-daily injection of enoxaparin at the dosage of 1.5 mg/kg is approved for inpatient (hospital) treatment of PE in the United States and in some, but not all, European countries.
bIn cancer patients, dalteparin is given at a dose of 200 IU/kg body weight (maximum, 18 000 IU) once daily over a period of 1 month, followed by 150 IU/kg once daily for 5 months.278 After this period, anticoagulation with a vitamin K antagonist or a LMWH should be continued indefinitely or until the cancer is considered cured.
cNadroparin is approved for treatment of PE in some, but not all, European countries.
Low molecular weight heparin and pentasaccharide (fondaparinux) approved for the treatment of pulmonary embolism
|
|
All regimens administered subcutaneously.
IU = international units; LMWH = low molecular weight heparin.
aOnce-daily injection of enoxaparin at the dosage of 1.5 mg/kg is approved for inpatient (hospital) treatment of PE in the United States and in some, but not all, European countries.
bIn cancer patients, dalteparin is given at a dose of 200 IU/kg body weight (maximum, 18 000 IU) once daily over a period of 1 month, followed by 150 IU/kg once daily for 5 months.278 After this period, anticoagulation with a vitamin K antagonist or a LMWH should be continued indefinitely or until the cancer is considered cured.
cNadroparin is approved for treatment of PE in some, but not all, European countries.
